Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation

Abstract Many patients discontinue endocrine therapy for breast cancer due to intolerance. Identification of patients at risk for discontinuation is challenging. The minimal important difference (MID) is the smallest change in a score on a patient-reported outcome (PRO) that is clinically significan...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Karen Lisa Smith, Neha Verma, Amanda L. Blackford, Jennifer Lehman, Kelly Westbrook, David Lim, John Fetting, Antonio C. Wolff, Daniela Jelovac, Robert S. Miller, Roisin Connolly, Deborah K. Armstrong, Raquel Nunes, Kala Visvanathan, Carol Riley, Katie Papathakis, Nelli Zafman, Jennifer Y. Sheng, Claire Snyder, Vered Stearns
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Nature Portfolio 2022-04-01
Sarja:npj Breast Cancer
Linkit:https://doi.org/10.1038/s41523-022-00414-0
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia